Screener / SEC EDGAR /CIK 0001668397 /10-K filed Feb 10, 2026, compared with Feb 11, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Research Services

Medpace Holdings, Inc. MEDP

Compare with peers Embed
Planned sales, announced before they happen

3 trading plans running, 20 Form 144 notices for $365.0M

10-Q, 10-K and Form 144

What MEDP's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Jul 24, 2025 to Feb 16, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Kevin M. Brady
Chief Financial Officer and Treasurer
Adopted other arrangement Aug 20, 2026 10-Q Oct 22, 2026
August J. Troendle
Chief Executive Officer, President and Chairman of the Board
Adopted other arrangement Jul 27, 2026 10-Q Oct 22, 2026
Susan E. Burwig
Executive Vice President, Operations
Adopted other arrangement Jul 27, 2026 10-Q Oct 22, 2026
Brad W. Hansman
Executive Vice President, Operations
Ended other arrangement Jun 4, 2026 10-Q Jul 23, 2026
Stephen P. Ewald
General Counsel and Corporate Secretary
Adopted other arrangement Apr 27, 2026 10-Q Jul 23, 2026
August J. Troendle
Chief Executive Officer and Chairman of the Board
Ended other arrangement Dec 4, 2025 10-K Feb 10, 2026
Susan E. Burwig
Executive Vice President, Operations
Adopted other arrangement Nov 24, 2025 10-K Feb 10, 2026
Kevin M. Brady
Chief Financial Officer and Treasurer
Adopted other arrangement Nov 21, 2025 10-K Feb 10, 2026
Jesse J. Geiger
President
Adopted 10b5-1 plan Oct 27, 2025 10-K Feb 10, 2026
Susan E. Burwig
Executive Vice President, Operations
Adopted other arrangement Sep 3, 2025 10-Q Oct 23, 2025
August J. Troendle
Chief Executive Officer and Chairman of the Board
Ended other arrangement Aug 1, 2025 10-Q Oct 23, 2025
Stephen P. Ewald
General Counsel and Corporate Secretary
Adopted other arrangement Jul 28, 2025 10-Q Oct 23, 2025
Jesse J. Geiger
President
Adopted 10b5-1 plan Jul 24, 2025 10-Q Oct 23, 2025
Kevin M. Brady
Chief Financial Officer and Treasurer
Adopted other arrangement Jul 24, 2025 10-Q Oct 23, 2025
Robert O. Kraft
Director
Adopted other arrangement Aug 22, 2024 10-Q Oct 22, 2024
Susan E. Burwig
Executive Vice President, Operations
Adopted other arrangement Jun 5, 2024 10-Q Jul 23, 2024
August J. Troendle
Chief Executive Officer and Chairman of the Board
Ended other arrangement May 30, 2024 10-Q Jul 23, 2024
Susan E. Burwig
Executive Vice President, Operations
Adopted other arrangement Mar 15, 2024 10-Q Apr 23, 2024
August J. Troendle
Chief Executive Officer and Chairman of the Board of the Company
Adopted other arrangement Mar 7, 2024 10-Q Apr 23, 2024
Jesse J. Geiger
President
Adopted other arrangement Mar 4, 2024 10-Q Apr 23, 2024
Ashley M. Keating
Director
Adopted other arrangement Feb 26, 2024 10-Q Apr 23, 2024
Susan E. Burwig
Executive Vice President, Operations
Adopted other arrangement Dec 14, 2023 10-K Feb 13, 2024
August J. Troendle
Chief Executive Officer and Chairman of the Board of the Company
Adopted other arrangement Nov 29, 2023 10-K Feb 13, 2024
August J. Troendle
Chief Executive Officer and Chairman of the Board of the Company
Ended 10b5-1 plan Sep 21, 2023 10-Q Oct 24, 2023
Kevin M. Brady
Chief Financial Officer and Treasurer
Adopted other arrangement Jul 31, 2023 10-Q Oct 24, 2023
Stephen P. Ewald
General Counsel and Corporate Secretary
Adopted other arrangement Jul 26, 2023 10-Q Oct 24, 2023
August J. Troendle
Chief Executive Officer and Chairman of the Board of the Company
Adopted 10b5-1 plan May 1, 2023 10-Q Jul 25, 2023
Show the other 19 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 25, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 29, 2026 EWALD STEPHEN P
Officer
1,245 $859K
Oct 27, 2026 BURWIG SUSAN E
Officer
3,940 $2.7M
Oct 26, 2026 BURWIG SUSAN E
Officer
16,060 $10.9M
Aug 26, 2026 Kraft Robert O.
Director
3,858 $2.4M
Aug 20, 2026 Brady Kevin M.
Officer
3,400 $2.1M
Aug 19, 2026 Carley Brian T
Director
5,000 $3.0M
Aug 19, 2026 DAVENPORT FRED B JR
Director
7,283 $4.4M
Aug 11, 2026 McCarthy Cornelius P. III
Director
1,140 $690K
Aug 7, 2026 McCarthy Cornelius P. III
Director
795 $465K
Jul 29, 2026 GEIGER JESSE J
Former Officer
11,000 $7.0M
Jul 28, 2026 BURWIG SUSAN E
Officer
7,500 $4.5M
Jul 28, 2026 GEIGER JESSE J
Former Officer
4,000 $2.4M
Jul 27, 2026 August J. Troendle
Chairman
307,959 $184.8M
Jul 23, 2026 GEIGER JESSE J
Former Officer
11,000 $7.0M
May 28, 2026 EWALD STEPHEN P
Officer
16,349 $7.4M
Mar 17, 2026 GEIGER JESSE J
Officer
31,707 $14.5M
Nov 25, 2025 August J. Troendle
Chairman
150,000 $92.2M
Nov 24, 2025 BURWIG SUSAN E
Officer
20,000 $12.2M
Nov 21, 2025 Brady Kevin M.
Officer
3,000 $1.8M
Nov 14, 2025 Kraft Robert O.
Director
6,472 $3.8M
Show the other 12 notices

From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MEDP/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.